Related Experiment Video
Updated: Sep 17, 2025

A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb BCG lux/M.Tb lux
Published on: September 14, 2011
Vitamin D supplementation for tuberculosis prevention: A meta-analysis
Sheng Liu1, Tianyu Lin1, Yanyu Pan1
1The Second Department of Infection, 900th Hospital of PLA Joint Logistic Support Force, Fuzhou, Fujian Province, China.
Vitamin D supplementation does not significantly prevent tuberculosis infection or disease progression. This systematic review found no protective effect, though vitamin D was safe and well-tolerated in participants.
Area of Science:
- Immunology
- Infectious Diseases
- Nutritional Science
Background:
- Vitamin D is crucial for immune function, suggesting a potential role in tuberculosis (TB) prevention.
- Existing clinical evidence on vitamin D's efficacy against TB is inconsistent.
Purpose of the Study:
- To systematically review and meta-analyze randomized controlled trials (RCTs).
- To assess the impact of vitamin D supplementation on preventing TB infection and progression to active disease.
Main Methods:
- Searched major databases (PubMed, Embase, Cochrane, Web of Science) through January 2025.
- Included RCTs with participants free of active TB at baseline.
- Calculated pooled odds ratios (ORs) using random-effects models and evaluated evidence certainty with GRADE.
Main Results:
- Six RCTs (15,677 participants) were analyzed.
- Vitamin D supplementation showed no significant reduction in TB infection risk (OR: 0.95; 95% CI: 0.79-1.14) or progression to active TB (OR: 0.77; 95% CI: 0.56-1.05).
- Evidence certainty was moderate; no significant difference in adverse events was observed.
Conclusions:
- Vitamin D supplementation does not appear to significantly reduce the risk of tuberculosis infection or disease.
- Vitamin D supplementation is safe and well-tolerated for TB prevention studies.
- Further research may be needed to clarify vitamin D's role in specific populations or contexts.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Role of Skin in Vitamin D Synthesis
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...

